“ Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs? ”, Clinics, vol. 66, no. 7, pp. 1171–1175, Jan. 2011, doi: 10.1590/S1807-59322011000700008.